Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022
Freedman, R.A., Heiling, H.M., Li, T., Trapani, D., Tayob, N., Smith, K.L., Davis, R., Pereslete, A.M., DeMeo, M.K., Cotter, C., Chen, W.Y., Parsons, H.A., Santa-Maria, C.A., Van Poznak, C., Moy, B., Brufsky, A.M., Melisko, M.E., O’Sullivan, C.C., Ashai, N., Rauf, Y., Nangia, J.R., Burns, R.T., Savoie, J., Wolff, A.C., Winer, E.P., Rimawi, M.F., Krop, I.E., Lin, N.U.
Published in Annals of oncology (06.07.2024)
Published in Annals of oncology (06.07.2024)
Get full text
Journal Article
Local Therapy Outcomes and Toxicity From the ATEMPT Trial (TBCRC 033), a Phase II Randomized Trial of Adjuvant T-DM1 vs. TH in Women With Stage I HER2 Positive Breast Cancer
Bellon, J.R., Tayob, N., Burstein, H.J., Partridge, A., Demeo, M.K., Tralins, J., Yang, D.D., Dang, C., Isakoff, S.J., Yardley, D., Valero, V., Winer, E., Krop, I., Tolaney, S.
Published in International journal of radiation oncology, biology, physics (01.11.2021)
Published in International journal of radiation oncology, biology, physics (01.11.2021)
Get full text
Journal Article
6P Combined analysis of the HER2DX genomic tool in adjuvant APT and ATEMPT trials
Tarantino, P., Villacampa, G., Graham, N., Waks, A.G., Gonzalez, P. Villagrasa, Brasó-Maristany, F., Torres, E. Sanfeliu, Galván, P., Brunet, L. Pare, Demeo, M.K., Partridge, A.H., Burstein, H.J., Krop, I., Tayob, N., Winer, E.P., Prat, A., Tolaney, S.M.
Published in ESMO open (01.05.2023)
Published in ESMO open (01.05.2023)
Get full text
Journal Article
Phase Ib dose-escalation trial of taselisib (GDC-0032) in combination with HER2-directed therapies in patients with advanced HER2+ breast cancer
Grinshpun, A., Ren, S., Graham, N., DeMeo, M.K., Wrabel, E., Carter, J., Tayob, N., Pereslete, A., Hamilton, E., Juric, D., Mayer, E.L., Tolaney, S.M., Krop, I.E., Metzger, O.
Published in ESMO open (01.06.2024)
Published in ESMO open (01.06.2024)
Get full text
Journal Article